SciSparc (NASDAQ:SPRC) Trading 5.7% Higher – Here’s Why

SciSparc Ltd. (NASDAQ:SPRC)’s share price rose 5.7% during trading on Tuesday . The company traded as high as $0.24 and last traded at $0.24. Approximately 372,075 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 1,581,137 shares. The stock had previously closed at $0.23.

SciSparc Stock Performance

The business has a 50 day moving average of $0.24 and a two-hundred day moving average of $0.56.

Institutional Trading of SciSparc

An institutional investor recently bought a new position in SciSparc stock. Renaissance Technologies LLC acquired a new position in shares of SciSparc Ltd. (NASDAQ:SPRC) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 39,700 shares of the company’s stock, valued at approximately $32,000. Renaissance Technologies LLC owned approximately 5.59% of SciSparc as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 25.06% of the company’s stock.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.